Drug shortage
Cetrorelix Acetate Injection · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · To Be Discontinued · updated Nov 13, 2025
Key facts
| Generic name | Cetrorelix Acetate Injection |
|---|---|
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Cetrorelix Acetate, Injection, Kit (NDC 0480-5795-08) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Reproductive |
| Package NDCs | 0480-5795-08 |
| First posted | Nov 13, 2025 |
| Last updated | Nov 13, 2025 |
| Discontinued | Nov 13, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: